Clinical Trials in San Antonio

Showing 6301-6320 of 14,633 trials

To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer

NCT04843319

To determine an effective dose of VERU-100 for the treatment of advanced prostate cancer by assessing its effect on testosterone levels by Day 28 and maintenance through Day 91.

Advanced Prostate Adenocarcinoma

Veru Inc.24 participantsStarted Jun 2021

Tucson, Arizona, United States • Tucson, Arizona, United States • San Bernardino, California, United States +8 more locations

COMPLETEDPhase 2< 1 mile

A 6 Month Safety Extension Study of MBGS205

NCT02908074

Phase IIb, multicentre, double-blind, randomised, placebo-controlled parallel-group 36-week study evaluating safety and efficacy of BGS649 in male obese subjects with hypogonadotropic hypogonadism (HH)

Hypogonadotropic Hypogonadism

Mereo BioPharma143 participantsStarted Nov 2016

Mobile, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +34 more locations

To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer

A 6 Month Safety Extension Study of MBGS205

Find Trials by Condition in San Antonio

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease

P3 Long Term Safety Study of Once Daily SB204 in Acne

Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury

Study of ASN003 in Subjects With Advanced Solid Tumors

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2

Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Promoting The Self-Regulation Of Energy Intake

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)

rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study

Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis